Why in news?
C-Reactive Protein (CRP) continues to gain attention in recent medical research for its role as an inflammation biomarker, with updates on point-of-care testing, predictive models, and prognostic applications in diseases like COPD, cardiovascular conditions, and cancer. Studies from late 2025 and early 2026 highlight CRP's utility in reducing antibiotic overuse and enhancing risk stratification.​
About CRP
- Definition: CRP is a protein made by the liver and released into the bloodstream when there is inflammation.
- Biological role: It is part of the innate immune system, binding to dead or dying cells and certain bacteria to activate the complement system.
- Gene location: In humans, the CRP gene is located on chromosome 1q23.2
Clinical Uses
- Healthcare providers use CRP tests to detect inflammation from bacterial infections, autoimmune diseases like rheumatoid arthritis or lupus, and cardiovascular risk assessment via high-sensitivity CRP (hsCRP).
- Levels guide sepsis treatment, monitor chronic conditions such as inflammatory bowel disease, and predict heart disease risk independently of cholesterol.​
CRP Levels and Interpretation
| CRP Level (mg/L) |
Interpretation |
| < 1 |
Low risk of inflammation; minimal cardiovascular risk |
| 1 – 3 |
Moderate risk; possible mild inflammation |
| > 3 |
High risk; significant inflammation or infection |
| > 10 |
Strong indication of acute infection or major inflammation |
Risks & Precautions
- Non-specific marker: CRP indicates inflammation presence but not its cause or location, requiring correlation with symptoms and other tests.
- Temporary elevation: Levels can rise after surgery, trauma, or even intense exercise.
- Cardiac risk: High-sensitivity CRP (hs-CRP) is specifically used for predicting heart attack or stroke risk, but should be interpreted alongside other risk factors.
Download Pdf
